Literature DB >> 24837269

Three-dimensional echocardiography and cardiac magnetic resonance imaging in the screening of long-term survivors of childhood cancer after cardiotoxic therapy.

Kaisa Ylänen1, Anneli Eerola2, Kim Vettenranta3, Tuija Poutanen4.   

Abstract

The left ventricular (LV) volumes, ejection fraction (EF), and dyssynchrony indexes for the 16 and 12 cardiac segments (Tmsv16-SD and Tmsv12-SD, respectively) were analyzed among nonadult, anthracycline-exposed long-term survivors of childhood cancer and compared with those of healthy controls using conventional and real-time 3-dimensional echocardiography (RT-3DE) with cardiac magnetic resonance (CMR) imaging in a prospective, cross-sectional, single tertiary center setting. Seventy-one survivors and gender-, body surface area-, and age-matched healthy controls were studied by conventional echocardiography and RT-3DE. Fifty-eight of the 71 survivors underwent also CMR. The survivors were evaluated in 2 groups. Group I consisted of 63 exposed to anthracyclines and group II consisted of 8 also exposed to cardiac irradiation. By RT-3DE, the group I survivors had a lower LVEF (57% vs 60%, respectively, p = 0.003) and larger body surface area-indexed LV end-systolic volume (31 vs 28 ml/m(2), respectively, p = 0.001) than controls. The Tmsv16-SD was higher in group II than in I (1.93% vs 1.39%, respectively, p = 0.003). None of the survivors had an abnormal fractional shortening (<28%), but 10% had an LVEF <50% by RT-3DE. An LVEF <55% was detected in 45 of 58 (78%) of those imaged with CMR. In conclusion, RT-3DE seems to detect more abnormalities in cardiac function than conventional echocardiography following childhood cancer therapy. The LV dyssynchrony indexes derived from RT-3DE appear potentially useful in assessing the early signs of cardiotoxicity between anthracycline and cardiac irradiation exposed long-term survivors of childhood cancer.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24837269     DOI: 10.1016/j.amjcard.2014.03.019

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  12 in total

Review 1.  An update on cardio-oncology.

Authors:  Joerg Herrmann; Amir Lerman
Journal:  Trends Cardiovasc Med       Date:  2014-07-22       Impact factor: 6.677

2.  Detection of Cardiac Toxicity Due to Cancer Treatment: Role of Cardiac MRI.

Authors:  Nandini Nina M Meyersohn; Amit Pursnani; Tomas G Neilan
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-08

Review 3.  Cardiovascular Imaging in Cardio-Oncology: The Role of Echocardiography and Cardiac MRI in Modern Cardio-Oncology.

Authors:  John Alan Gambril; Aaron Chum; Akash Goyal; Patrick Ruz; Katarzyna Mikrut; Orlando Simonetti; Hardeep Dholiya; Brijesh Patel; Daniel Addison
Journal:  Heart Fail Clin       Date:  2022-07       Impact factor: 2.828

4.  Speckle tracking echocardiography detects decreased cardiac longitudinal function in anthracycline-exposed survivors of childhood cancer.

Authors:  Kaisa Ylänen; Anneli Eerola; Kim Vettenranta; Tuija Poutanen
Journal:  Eur J Pediatr       Date:  2016-09-13       Impact factor: 3.183

Review 5.  Echocardiography and Alternative Cardiac Imaging Strategies for Long-Term Cardiotoxicity Surveillance of Cancer Survivors Treated with Chemotherapy and/or Radiation Exposure.

Authors:  Vinisha Garg; Gabriel Vorobiof
Journal:  Curr Oncol Rep       Date:  2016-08       Impact factor: 5.075

Review 6.  The role of notch in the cardiovascular system: potential adverse effects of investigational notch inhibitors.

Authors:  Paola Rizzo; Donato Mele; Cristiana Caliceti; Micaela Pannella; Cinzia Fortini; Anthony George Clementz; Marco Bruno Morelli; Giorgio Aquila; Pietro Ameri; Roberto Ferrari
Journal:  Front Oncol       Date:  2015-01-13       Impact factor: 6.244

7.  Cardiotoxicity due to chemotherapy for breast cancer: the dark side of the moon.

Authors:  Mariangela Peruzzi; Giovanni Palazzoni; Giuseppe Biondi-Zoccai; Marzia Lotrionte
Journal:  Anatol J Cardiol       Date:  2014-12-25       Impact factor: 1.596

8.  Native myocardial T1 time can predict development of subsequent anthracycline-induced cardiomyopathy.

Authors:  Fabian Muehlberg; Stephanie Funk; Leonora Zange; Florian von Knobelsdorff-Brenkenhoff; Edyta Blaszczyk; Alexander Schulz; Saeed Ghani; Annete Reichardt; Peter Reichardt; Jeanette Schulz-Menger
Journal:  ESC Heart Fail       Date:  2018-04-19

9.  Cardiac Surveillance for Early Detection of Late Subclinical Cardiac Dysfunction in Childhood Cancer Survivors After Anthracycline Therapy.

Authors:  Rosaria Sofia; Veronica Melita; Antonio De Vita; Antonio Ruggiero; Alberto Romano; Giorgio Attinà; Lisa Birritella; Priscilla Lamendola; Antonella Lombardo; Gaetano Antonio Lanza; Angelica Bibiana Delogu
Journal:  Front Oncol       Date:  2021-05-14       Impact factor: 6.244

10.  Left ventricular dyssynchrony in long-term childhood cancer survivors treated with anthracyclines: a retrospective cross-sectional study.

Authors:  Milanthy S Pourier; Myrthe M Dull; Gert Weijers; Jacqueline Loonen; Louise Bellersen; Chris L de Korte; Livia Kapusta; Annelies M C Mavinkurve-Groothuis
Journal:  Int J Cardiovasc Imaging       Date:  2021-08-06       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.